The “How” In Part 1 of this series, I debunked common misconceptions around using data to improve clinical trials. In Part 2, I discussed the validation of digital health tools, and how to tell which tools might actually enact behavior change. Now, in Part 3, I’d like to look at how pharmaceutical companies can actually build a step-by-step plan for implementing data-driven and agile clinical trial processes that will save time and money. In an attempt to strip down...









